Cited by 13Pharmaceutical studies and practicesAnimal testing and alternativesPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The Correction Factors Do Help in Improving the Prediction of Human Clearance from Animal Data

Mahmood, Iftekhar·2005·Journal of Pharmaceutical Sciences

Overview

Integrity signals

Registry

Crossref · 10.1002/jps.20299

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 43

  1. Wajima, 2002, Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis, J Pharm Sci, 91, 2489, 10.1002/jps.10242 · DOI
  2. Boxenbaum, 1984, Scaling of antipyrine intrinsic clearance of unbound drug on 15 mammalian species, Eur J Drug Metab Pharmacokinet, 9, 177, 10.1007/BF03189622 · DOI
  3. Obach, 1997, The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism, J Pharmacol Exp Ther, 283, 46
  4. Karalis, 2002, Drug disposition viewed in terms of the fractal volume of distribution, Pharm Res, 19, 696
  5. Davies, 1993, Physiological parameters in laboratory animals and humans, Pharm Res, 10, 1093, 10.1023/A:1018943613122 · DOI
  6. Mahmood, 2002, Interspecies scaling of biliary excreted drugs, J Pharm Sci, 91, 1908, 10.1002/jps.10174 · DOI · Paper page
  7. Duhart, 1993, Pharmacokinetics of cocaine in pregnant and nonpregnant rhesus monkeys, Reprod Toxicol, 7, 429, 10.1016/0890-6238(93)90087-N · DOI
  8. Clement, 1990, Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatta): Effect of atropine, diazepam, and methoxyflurane anesthesia, Biopharm Drug Dispos, 11, 227, 10.1002/bdd.2510110307 · DOI
  9. de Miranda, 1982, Species differences in the disposition of acyclovir, Am J Med, 73, 31, 10.1016/0002-9343(82)90059-6 · DOI
  10. Johnson, 1985, Metabolism and disposition of amifloxacin in laboratory animals, Antimicrob Agents Chemother, 27, 774, 10.1128/AAC.27.5.774 · DOI
  11. El Dareer, 1977, Distribution and metabolism of prednisone in mice, dogs, and monkeys, Cancer Treat Rep, 61, 1279
  12. El Dareer, 1977, Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys, Cancer Treat Rep, 61, 1269
  13. Yeung, 1983, Drug–protein conjugates—IV. The effect of acute renal failure on the disposition of [14C]captopril in the rat, Biochem Pharmacol, 32, 2467, 10.1016/0006-2952(83)90003-5 · DOI
  14. Tse, 1990, Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey, Biopharm Drug Dispos, 11, 519, 10.1002/bdd.2510110606 · DOI
  15. Chang, 1987, Preclinical and clinical pharmacokinetics of pirmenol, Am J Cardiol, 59, 15H, 10.1016/0002-9149(87)90139-1 · DOI
  16. Sanwald-Ducray, 1997, Prediction of the pharmacokinetic parameters of reduced dolasetron in man using in vitro-in vivo and interspecies allometric scaling, Xenobiotica, 27, 189, 10.1080/004982597240686 · DOI
  17. Dockens, 2000, Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans, Drug Metab Dispos, 28, 973
  18. Maruhn, 1985, Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey, Arzneimittelforschung, 35, 1781
  19. Salmon, 1983, Pharmacokinetics and metabolism of moxestrol in animals: Rat, dog and monkey, J Steroid Biochem, 19, 1223, 10.1016/0022-4731(83)90421-1 · DOI
  20. Salmon, 1983, Pharmacokinetics and metabolism of moxestrol in humans, J Steroid Biochem, 18, 565, 10.1016/0022-4731(83)90132-2 · DOI
  21. Turner, 1975, Influence of route of administration on metabolism of [14C]nicotine in four species, Xenobiotica, 5, 553, 10.3109/00498257509056125 · DOI
  22. Runkel, 1972, Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects, J Pharm Sci, 61, 703, 10.1002/jps.2600610507 · DOI
  23. Boyes, 1970, Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs, J Pharmacol Exp Ther, 174, 1
  24. Sawada, 1984, Prediction of the disposition of β-lactam antibiotics in humans from pharmacokinetic parameters in animals, J Pharmacokin Biopharm, 12, 241, 10.1007/BF01061720 · DOI
  25. Eriksson, 1998, Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug, Biopharm Drug Dispos, 19, 55, 10.1002/(SICI)1099-081X(199801)19:1<55::AID-BDD74>3.0.CO;2-H · DOI
  26. Cruze, 1995, Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology, Pharm Res, 12, 895, 10.1023/A:1016273306956 · DOI
  27. Lave, 1996, Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor, J Pharm Pharmacol, 48, 573, 10.1111/j.2042-7158.1996.tb05976.x · DOI
  28. Ritschel, 1991, Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species, Methods Find Exp Clin Pharmacol, 13, 697
  29. Giachetti, 1998, Pharmacokinetic study in dogs and monkeys after single intravenous and oral administrations of [14C]-ITF-296, Eur J Drug Metab Pharmacokin, 23, 239, 10.1007/BF03189346 · DOI
  30. Monzani, 1995, Pharmacokinetic profile of ITF 296 in rats and dogs, J Cardiovasc Pharmacol, 269, S67, 10.1097/00005344-199526004-00012 · DOI
  31. Sardina, 1995, Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers, J Cardiovasc Pharmacol, 269, S72, 10.1097/00005344-199526004-00013 · DOI
  32. Monzani, 1999, Pharmacokinetics of ITF 296 (Sinitrodil) a novel organic nitrate, in healthy volunteers, Eur J Pharm Sci, 7, 179, 10.1016/S0928-0987(98)00026-8 · DOI
  33. Cook, 1993, Pharmacokinetics of a novel antiarrhythmic drug, actisomide, Pharm Res, 10, 427, 10.1023/A:1018900725050 · DOI
  34. Tanaka, 1999, In vivo and in vitro trimethadione oxidation activity of the liver from various animal species including mouse, hamster, rat, rabbit, dog, monkey and human, Hum Exp Toxicol, 18, 12, 10.1191/096032799678839356 · DOI
  35. Efthymiopoulos, 1991, Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibiotic, J Antimicrob Chemother, 4, 517, 10.1093/jac/27.4.517 · DOI
  36. Jannuzzo, 1989, Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose, Eur J Clin Pharmacol, 36, 633, 10.1007/BF00637750 · DOI
  37. Doyle, 1982, Comparative pharmacokinetics of frusemide in female rhesus monkeys, cynomolgus monkeys and baboons, Comp Biochem Physiol C, 71C, 89, 10.1016/0306-4492(82)90015-6 · DOI
  38. Hirai, 1992, The pharmacokinetics and pharmacodynamics of furosemide in the anaesthetized dog, J Vet Pharmacol Ther, 15, 231, 10.1111/j.1365-2885.1992.tb01011.x · DOI
  39. Prandota, 1991, Pharmacokinetic, biliary excretion, and metabolic studies of 14C-furosemide in the rat, Xenobiotica, 21, 725, 10.3109/00498259109039512 · DOI
  40. Teng, 1996, Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys, Antimicrob Agents Chemother, 40, 561, 10.1128/AAC.40.3.561 · DOI
  41. Vincent, 1997, Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin, J Antimicrob Chemother, 39, 75, 10.1093/jac/39.suppl_2.75 · DOI
  42. Ivarone, 1999, First time in human for GV196771: Interspecies scaling applied on dose selection, J Clin PharmacoI, 39, 560, 10.1177/00912709922008164 · DOI
  43. Ward, 2004, A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance, Drug Metab Dispos, 32, 603, 10.1124/dmd.32.6.603 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Mahmood, I.
Affiliations
United States Food and Drug Administration (US)
Corresponding author
Mahmood, Iftekhar
Venue
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2005-05
Volume
94
Issue
5
Pages
940-945
ISSN
0022-3549 (ISSN-L)
OpenAlex
W2083159335
Cited by
13
References
3
Citations by year
2019: 2 · 2014: 2 · 2012: 1
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pharmaceutical Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
animal-to-human extrapolation, correction factors, pharmacokinetics, interspecies scaling
MeSH terms
Algorithms, Animals, Chemistry, Pharmaceutical, Data Interpretation, Statistical, Pharmaceutical Preparations, Humans, Pharmacokinetics, Predictive Value of Tests, Species Specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review